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ABSTRACT
Aims/Introduction: We aimed to investigate the long-term trajectory of general adi-
posity assessed by the body mass index (BMI) before the onset of type 2 diabetes in Jap-
anese individuals.
Materials and Methods: We retrospectively examined data on 1,553 Japanese men
without diabetes. Mean BMI and incident cases of diabetes (diabetes indicated by fasting
glucose concentrations ≥7.0 mmol/L, a self-reported history of clinician-diagnosed diabe-
tes, or glycated hemoglobin ≥6.5% (≥48 mmol/mol) were assessed on an annual basis
over a 10-year period after the baseline examination.
Results: Mean (standard deviation) BMI at the time of diagnosis was 24.4 kg/m2
(3.1 kg/m2) among cases of diabetes (n = 191). An increasingly high BMI was associated
with the early stage of the disease development, such as an 8- to 10-year prediagnosis
period; individuals who developed diabetes experienced a prolonged and stable elevated
BMI of ≥24.4 kg/m2 over the 8 years before the diagnosis of diabetes. The mean BMI
among the non-cases of diabetes did not exceed 23.2 kg/m2 throughout the period.
Conclusions: These results suggested that Japanese men who eventually developed
diabetes during the 10-year observation period were not characterized as obese, but had
stable high-normal BMIs before the onset of diabetes. Previous evidence showed that val-
ues for glycemic markers rapidly increased before the development of diabetes; however,
the present study showed a slight gain in BMI in the earlier stage of the natural history of
diabetes followed by a prolonged period of overweight.
INTRODUCTION
A large body of evidence has shown that elevated body mass
index (BMI), gain in weight or BMI, and the duration of over-
weight or obesity were associated with an increased risk of the
development of type 2 diabetes1–12. According to data on the
trajectory of BMI from adolescence to young adulthood, men
who eventually developed diabetes had higher BMIs during
adulthood, such as around ages 30–45 years, compared with
data for an entire study population13. The weight history of
newly diagnosed diabetic patients was also investigated14,15, and
it was reported that the highest mean BMI generally occurred
at or immediately after diagnosis14. Nevertheless, the studies
only included individuals with diagnosed diabetes, and the
study was not designed to compare results among cases and
non-cases of diabetes14,15. A few studies have investigated the
long-term trajectory of BMI before the onset of diabetes in
comparison with individuals free of diabetes using data from
repeated clinical measurements during follow-up examinations
of USA and Western adult participants16–18. In general, AsiansReceived 6 August 2014; revised 7 October 2014; accepted 31 October 2014
ª 2014 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd J Diabetes Invest Vol. 6 No. 3 May 2015 289
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution
in any medium, provided the original work is properly cited, the use is non-commercial and no modiﬁcations or adaptations are made.
ORIGINAL ARTICLE
have a higher prevalence of type 2 diabetes, although they have
lower BMI levels than people of European descent19,20. A cross-
sectional study that compared general obesity in treated patients
with diabetes in Japan and in the UK showed a great difference
in the degree of obesity between the two ethnicities, even
though the two cohorts had similar characteristics regarding
clinical markers other than BMI21. Longitudinal data on the
trajectory of general adiposity with repeated clinical measure-
ments before the actual onset of type 2 diabetes are sparse,
especially in Asian individuals who are not predominantly over-
weight or obese.
Furthermore, in Japanese individuals who eventually devel-
oped type 2 diabetes, glycated hemoglobin (HbA1c) and glu-
cose trajectories increased sharply after gradual long-term
increases22. The Whitehall II study, which was a prospective
study, showed changes in glucose concentrations, insulin sensi-
tivity and insulin secretion as much as 3–6 years before the
diagnosis of diabetes23. With reference to the rapid increases
in levels of glycemic concentrations before the diagnosis of
diabetes17,22–25, it remains unknown when in the natural his-
tory of diabetes an elevated BMI, an increasing BMI, or stable
overweight or obesity could be observed among individuals
who eventually develop type 2 diabetes. A better understand-
ing of the relationships of the BMI trajectory and BMI history
to the development of diabetes would help both clinicians and
patients prevent deterioration of the glycemic state, which
might have otherwise occurred. In the present study we inves-
tigated the trajectory of BMI and BMI histories before the




The Toranomon Hospital Health Management Center Study
included a cohort consisting mainly of apparently healthy gov-
ernment employees who underwent annual health examinations
for health screening in Tokyo, Japan. We retrospectively exam-
ined data on 1,634 men who underwent health examinations
on an annual basis during a 10-year follow-up period from
1997 to 2002 at the Health Management Center, Toranomon
Hospital. We excluded men who had diabetes at the baseline
examination (n = 81). Subsequently, 1,553 men without diabe-
tes aged 26–80 years were eligible for the current analysis.
Female participants were not included, because the database
did not contain a reasonable number of incident cases of diabe-
tes in women to carry out meaningful analyses (33 incident
cases/565 women after exclusions). Diagnosis of type 2 diabetes
was made according to the American Diabetes Association cri-
teria26 of fasting plasma glucose (FPG) level ≥7.0 mmol/L, a
self-reported history of clinician-diagnosed diabetes, or HbA1c
(National Glycohemoglobin Standardization Program) ≥6.5%
(≥48 mmol/mol). The study protocol followed the Japanese
Government’s Ethical Guidelines Regarding Epidemiological
Studies in accordance with the Declaration of Helsinki, and
was reviewed by the institutional review board at Toranomon
Hospital.
Clinical Measurements
Weight and height were measured at baseline and at each
annual follow-up examination, and BMI (kg/m2) was calcu-
lated. We assessed the maximum BMI during the follow-up
time before the diabetes diagnosis, and a history of excessive
obesity was indicated by BMI ≥27.5 kg/m2 in the present
study27. Blood samples were collected after an overnight fast
and measurements made using an automatic clinical chemistry
analyzer (LABOSPECT 008; Hitachi, Tokyo, Japan). Blood glu-
cose was measured by enzymatic methods and HbA1c was
assessed by high-performance liquid chromatography.
Statistical Analysis
From our retrospective examination of these data, we initially
divided the participants according to whether or not they had
developed diabetes during the total follow-up time. The inci-
dence of diabetes was assessed annually after the baseline exam-
ination. We diagnosed the incidence of diabetes if an elevated
fasting glucose, elevated HbA1c or a self-reported history of cli-
nician-diagnosis was ﬁrst observed at an individual’s annual
examination. Then we set a timeline with 0 (years) to show
the year of diagnosis of diabetes (incident cases of diabetes) or
the ﬁnal follow-up year (non-cases). BMI trajectories before the
development of diabetes were retrospectively evaluated from the
year of the baseline examination until the year of diagnosis of
diabetes or to the end of the follow-up period. We calculated
crude mean values for BMI, and the mean (95% conﬁdence
interval) is presented in Figure 1. As the time of the develop-
ment of diabetes varied among these individuals over the
course of the observational period, data to draw a trajectory
were not available for an entire 10-year period before diagnosis
for all incident cases. We assessed whether there was an associ-
ation between age and BMI with the diagnosis of diabetes
among individuals who developed diabetes. Analysis was car-
ried out with IBM SPSS Statistics version 19 (IBM, Armonk, NY,
USA).
RESULTS
We documented 191 incident cases of type 2 diabetes over the
10-year follow-up period (Table 1). At the baseline examina-
tion, the mean (standard deviation [SD]) BMI was 22.9 kg/m2
(2.6 kg/m2) and the mean age was 48.7 years (8.6 years) for
individuals who did not develop diabetes, and the mean BMI
was 24.2 kg/m2 (2.8 kg/m2) and mean age was 52.0 years
(8.6 years) for those who developed diabetes.
At the time of the diagnosis of diabetes, the mean (SD) BMI
was 24.4 kg/m2 (3.1 kg/m2) among cases of diabetes (Figure 1).
Individuals who eventually progressed to diabetes experienced
increasing levels of BMI in the early stage of the disease devel-
opment (during the 10- to 8-years period before the onset of
diabetes). Their mean BMI was 23.7 kg/m2 (2.3 kg/m2)
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10 years before diagnosis, and reached 24.5 kg/m2 (3.0 kg/m2)
8 years before diagnosis. Individuals who developed diabetes
experienced a prolonged and stable elevated BMI of ≥24.4 kg/
m2 (range 24.4–24.6 kg/m2) over the 8 years before the diagno-
sis of diabetes. In contrast, the mean BMI among individuals
who did not develop diabetes did not exceed 23.2 kg/m2
throughout the 10-year follow-up period. We also assessed inci-
dent cases of diabetes using different diagnostic criteria, which
were: (i) FPG ≥7.0 mmol/L or a self-reported history of clini-
cian-diagnosis (166 incident cases); or (ii) HbA1c ≥48 mmol/
mol or self-reported history of clinician-diagnosis (158 incident
cases). Results did not show a progressive increase in mean
BMIs in the late stages before the diagnosis of diabetes; the
mean BMIs among cases of diabetes were relatively stable
although elevated using these diagnostic criteria (Table S1).
When we assessed the maximum BMI and the history of exces-
sive obesity (BMI ≥27.5 kg/m2; Table 1), the mean maximum
BMI was higher among cases of diabetes than non-cases
(24.9 kg/m2 [3.0 kg/m2] vs 24.0 kg/m2 [2.7 kg/m2]; P < 0.001
by t-test). The prevalence of individuals with a history of exces-
sive obesity was also higher among diabetic individuals (16.2%
vs 10.1%; P = 0.011 by v2-test).
We observed a linear association between age and BMI at
the time of diagnosis of diabetes (Table 2). Individuals who
developed diabetes at an early age (<50 years) were more likely
to have an elevated BMI (mean [SD] 25.1 kg/m2 [3.7 kg/m2]
kg/m2) than those who developed diabetes at older ages (mean
[SD] BMI 23.8 kg/m2 [2.7 kg/m2] for those aged 60–64 years;
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Figure 1 | Trajectory of mean body mass index (95% confidence interval) among men who developed diabetes and who did not develop
diabetes during the follow-up period of 10 years. Data are crude mean values and 95% confidence intervals. Closed circles, incident cases of
diabetes; open circles, Non-diabetes cases.
Table 1 | Characteristics of study participants according to the incidence of type 2 diabetes during the follow-up period of 10 years
Characteristics Non-diabetes Diabetes
(n = 1362) Total Years before the development of diabetes
(n = 191) <4 years (n = 64) 4–7 years (n = 70) ≥8 years (n = 57)
Age at time of baseline examination (years) 48.7 – 8.6 52.0 – 8.6** 52.3 – 9.2 51.8 – 8.1 51.9 – 8.8
Parental history of diabetes 177 (13.0) 33 (17.3) 11 (17.2) 14 (20.0) 8 (14.0)
Fasting glucose (mmol/L) 5.3 – 0.4 5.8 – 0.5** 6.0 – 0.6 5.9 – 0.5 5.6 – 0.5
BMI at time of baseline examination (kg/m2) 22.9 – 2.6 24.2 – 2.8** 23.7 – 2.7 24.4 – 2.8 24.4 – 3.0
Age at time of final examination (years) 58.7 – 8.6 57.4 – 9.1 54.4 – 9.2 57.2 – 8.4 61.0 – 8.8
Maximum BMI during follow-up
examinations (kg/m2)
24.0 – 2.7 24.9 – 3.0** 24.1 – 2.8 25.2 – 3.0 25.5 – 3.1
History of excessive obesity (BMI ≥27.5) 138 (10.1) 31 (16.2)* 6 (9.4) 14 (20.0) 11 (19.3)
Data are n (%) or means – standard deviation unless otherwise indicated. BMI, body mass index. P-value was tested by t-test or v2-test for two
groups (non-diabetes cases vs total diabetes cases). **P < 0.001; *P < 0.05.
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mean BMI 23.6 kg/m2 [3.3 kg/m2] for those aged ≥65 years).
Results of our additional analysis in which participants were
stratiﬁed into two groups by age at the time of diabetes diagno-
sis showed that men who developed diabetes at younger ages
were more likely to have higher BMI levels in the late stage of
the disease progression than those who developed diabetes at
older ages (data not shown).
DISCUSSION
In this cohort of apparently healthy Japanese men, the mean
BMI value was 24.4 kg/m2 at the time of the diagnosis of
type 2 diabetes, whereas the mean BMI did not exceed
23.2 kg/m2 among who did not develop diabetes. Considering
our previous ﬁndings and those of other studies17,22–25 that the
glycemic trajectory increased sharply after gradual long-term
increases in individuals who progressed to diabetes, an opposite
pattern was seen regarding the BMI. Speciﬁcally, a gain in the
BMI was noted at an earlier stage followed by the maintenance
of a high-normal mean BMI in the later stages before diagnosis,
at which time glycemic indicators were shown to rapidly
increase.
Although we did not observe a steady and marked mean
BMI gain throughout the observational time among the indi-
viduals who developed diabetes, it was reported that there was
a progressive rise in weight before the diagnosis of diabetes in
Pima Indians14, and that the highest mean BMI generally
occurred at or immediately after diagnosis14. In contrast, the
average weight gain from 10 years before diabetes was only
1 kg among newly diagnosed Danish diabetic patients15. In a
longitudinal study16 of participants from the Framingham
Heart Study Offspring cohort, the mean BMI was 31.7 kg/m2
at the time of diagnosis and 30.1 kg/m2 at 10 years before the
diagnosis of diabetes. Compared with ﬁndings in USA adults16,
the mean BMI at the time of the diagnosis of diabetes was
remarkably lower in our cohort of Japanese men, whereas the
change in BMI over the 10-year follow-up period among indi-
viduals who eventually developed diabetes was of a similar
degree. Adult weight gain is usually mainly fat28, and individu-
als with an increased BMI over 15 years had progressively
worsening levels of metabolic risk proﬁles, including fasting glu-
cose and fasting insulin concentrations29. According to a cross-
sectional study of newly diagnosed patients with diabetes in
Japan, a slight increase in BMI and waist circumference might
have inﬂuenced the trend of decreases in fasting insulin con-
centrations over a decade30. A long duration of overweight/
obesity would increase the risk of diabetes6–8,10–12, and it was
reported that when the degree of adiposity persisted or became
high, insulin sensitivity was impaired and glycemic deterioration
occurred in lean Chinese adults31. A study of Whitehall II
cohort participants was recently published; the majority of
patients diagnosed with diabetes were classiﬁed as the “stable
overweight” group, and it was suggested that many patients
might not have a substantial weight gain in the later stage of
disease development18, which is in line with our observation.
The present results for Japanese individuals suggested that pro-
longed, elevated BMI levels even within the normal range inﬂu-
enced the deterioration of the glycemic state in men who
subsequently progressed to diabetes.
A study32 of USA adults diagnosed with type 2 diabetes
(~90% were non-Hispanic white, and 10% were African
American, Asian/Paciﬁc Islander, Native American and
Hispanic individuals) reported that the average BMI was
39 kg/m2 among younger participants, and that the older
participants had BMI 33 kg/m2. The onset of diabetes would
depend on BMI and age2,5,14,15,32, and reviews suggested that
people in Asia tend to develop diabetes with a lesser degree
of obesity and at younger ages19,20. Results of our longitudi-
nal study showed that the mean BMI at the time of diagno-
sis of diabetes was higher among those who developed
diabetes at a younger age than among those who developed
diabetes when older. The weight change pattern after a new
diagnosis of type 2 diabetes was reported to be predictive of
glycemic and blood pressure control33, and the present
results suggested that clinicians and patients should pay care-
ful attention to an elevated BMI and weight control at the
time of and after the diagnosis of diabetes, particularly in
younger adults.
The strengths of the present study included a long-term fol-
low up with repeated clinical measurements of weight, height,
FPG and HbA1c to diagnose type 2 diabetes. Nevertheless, we
only assessed general adiposity by BMI, and did not assess
changes in waist circumference and visceral fat accumulation.
It has been suggested that an accumulation of visceral fat over
5 years was independently associated with a greater risk of the
development of diabetes in Japanese Americans34. We did not
have available data on BMI 20 years or 30 years before the
Table 2 | Body mass index according to five age groups at the time of diagnosis of diabetes among individuals who developed diabetes
Age at the time of diagnosis of diabetes (years) P-trend
<50 50–54 55–59 60–64 ≥65
n 37 45 37 28 44 –
BMI at time of diagnosis of diabetes (kg/m2) 25.1 (3.7) 25.0 (2.9) 24.5 (2.6) 23.8 (2.7) 23.6 (3.3) 0.008
BMI at time of baseline examination (kg/m2) 25.0 (3.5) 24.4 (2.4) 24.1 (2.3) 23.7 (2.6) 23.6 (3.0) 0.015
Maximum BMI during follow-up examinations (kg/m2) 25.6 (3.7) 25.4 (2.7) 25.1 (2.6) 24.4 (2.6) 24.2 (3.2) 0.015
Data are crude mean (SD); n = 191. BMI, body mass index.
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diagnosis of diabetes, so we could not determine whether indi-
viduals who eventually developed diabetes might have levels of
BMI concordant with those who did not develop diabetes.
Also, we did not have available data on BMI across the life-
span of individuals, and could not investigate the inﬂuence of
BMI histories in childhood or in adolescence on our ﬁndings.
Further extensive studies would be required with data on
other obesity measures in long-term follow-up examinations.
The present study only included male participants. Females
were not investigated, because the number of female partici-
pants and incident cases of diabetes among women were not
sufﬁcient to draw a trajectory of BMI. An examination of sex
differences in the trajectory of adiposity, including data on
waist circumference, before the development of diabetes is
required. Because of our study design, the time to the inci-
dence of diabetes among cases varied over the course of the
observational period, and there were differences in the time
period for which the trajectory of BMI could be drawn
between cases and non-cases. A small number of individuals
were free from diabetes over a 9-year period after the baseline
examination, but progressed to diabetes in the last 1 year after
the 9-year prediabetic period. Data on oral glucose testing for
the diagnosis of diabetes were not available. The lack of data
on insulin and postprandial glucose concentrations during the
follow-up period did not allow us to carry out detailed assess-
ments of the pathophysiological background behind the devel-
opment of diabetes. Also, we could not distinguish incident
cases of type 1 diabetes during the follow-up period. As we
did not calculate the risk of diabetes by BMI changes with
adjustment for other factors, further investigations would be
required to examine the independent role of BMI changes in
the development of diabetes.
In conclusion, Japanese men who eventually developed dia-
betes over the 10-year period were not characterized by marked
obesity, but had stable high-normal BMIs (≥24 kg/m2). Consid-
ering previous evidence of glycemic trajectories before the
development of diabetes, a slight gain in BMI and a long-term
stable overweight state were observed in earlier stages of the
natural history of the development of diabetes than in later
stages, during which rapidly increasing levels of glycemic mark-
ers could be observed.
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